Transplants
Studies from Spain, Japan and the United Kingdom describe new findings in transplants research
Published in Blood Weekly, September 28th, 2006
Study 1: A study from Spain has reported on efficacy, predictors of response, and potential risks associated with antiviral therapy in liver transplant recipients with recurrent hepatitis C.
"There are unresolved issues regarding sustained virological response (SVR), tolerance and risk of rejection following antiviral therapy in liver transplantation (LT). The aim of our study was to determine efficacy, rejection risk and factors associated with SVR," wrote M. Berenguer and colleagues, Hospital Universitari La Fe.
"HCV-infected LT patients...
Want to see the full article?
We're a pay-per-view site for premium content. If you'd like to purchase this article, it's only $3.00.
Welcome to NewsRx!
Learn more about a six-week, no-risk free trial of Blood Weekly
Source: Blood Weekly (2006-09-28)
More Articles from Blood Weekly
- Blood Banking
Pall EBDS system detects bacteria in red blood cells - Blood Banking
Platelet binding and phagocytosis by macrophages is reduced using metabolic arrest - Blood Banking
Several factors affect bone marrow volume reduction and red blood cell depletion prior to transplant - Blood Transfusion
Efficacy of shipped HLA-matched platelets is reported - Leukapheresis
Leukapheresis under anesthesia safe and feasible in very low-weight noncompliant children - Acute Myeloid Leukemia
Leukemia linked to expression of B cell-specific activator protein - More from this issue of Blood Weekly
NewsRx is Social
Follow us on your favorite social network by clicking on a button below:
Top Medical Newsletters
Awards
Best Health/Healthcare Content, 2012
Best Health/Healthcare Content, 2011
Best e-Business Site, 2010
Best e-Business Site, 2009
Best e-Business Site, 2008
Best e-Business Site, 2007
Best e-Business Site, 2006
Best Healthcare Content, 2005
Best Overall Internet Site, 2005
Best Interactive Site, 2005
Facts & Stats
NewsRx also is available at LexisNexis, Gale, ProQuest, Factiva, Dialog, Thomson Reuters, NewsEdge, and Dow Jones.
- Google 2010 PageRank: #2 Among Top Health News and Media Publications
- Google 2010 PageRank: #2 Among Top Science Publications in Biology/Physiology
- Google 2010 PageRank: #2 Among Top News and Media for the Business of Pharmaceuticals
- Amazon's Alexa 2010 PageRank: #2 News and Media Site for the Pharmaceutical Industry
